Odyssey Therapeutics, Inc. (ODTX) vs SI-BONE, Inc. (SIBN)
A side-by-side comparison of Odyssey Therapeutics, Inc. and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ODTX
Odyssey Therapeutics, Inc.
$18.34HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
SIBN
SI-BONE, Inc.
$19.31HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — ODTX vs SIBN
growth of $100 · dividends reinvested · last 1yODTX +26.9% (+26.9%/yr)SIBN +52.5% (+52.5%/yr)SIBN compounded faster over this window
ODTX SIBN
ODTX vs SIBN: by the numbers
- •ODTX is the larger company ($881M vs $857M market cap).
- •Both run net losses; SIBN's is the smaller (-6.85% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | ODTX | SIBN |
|---|---|---|
| P/S ratio | N/A | 4.01 |
| P/B ratio | 2.09 | 4.70 |
Profitability
| Metric | ODTX | SIBN |
|---|---|---|
| Gross margin | 100.00% | 79.53% |
| Operating margin | -5415.19% | -8.31% |
| Net margin | -4994.86% | -6.85% |
| ROE | N/A | -8.03% |
| ROIC | -66.23% | -7.88% |
Growth (annualized)
| Metric | ODTX | SIBN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 20.20% |
| Total return CAGR (5Y) | N/A | -1.46% |
Go deeper
Dig into the metrics
Odyssey Therapeutics ROESI-BONE ROEOdyssey Therapeutics operating marginSI-BONE operating marginOdyssey Therapeutics revenue growthSI-BONE revenue growthOdyssey Therapeutics free cash flowSI-BONE free cash flow
Odyssey Therapeutics & SI-BONE appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.